Skip to Content

BeiGene, Ltd. (NASDAQ: BGNE)

Securities Class Action

  • Date:
  • 11/6/2019
  • Company Name:
  • BeiGene, Ltd.
  • Stock Symbol:
  • BGNE
  • Status:
  • Investigating

Case Finder

Locate any case using the tools below.

NEW YORK, November 6, 2019 –Bragar Eagel & Squire, P.C. is investigating potential claims against BeiGene, Ltd.  (NASDAQ: BGNE) on behalf of BeiGene stockholders. Our investigation concerns whether BeiGene has violated the federal securities laws and/or engaged in other unlawful business practices.

On September 5, 2019, J Capital Research (“J Capital”) published a report on BeiGene. The J Capital report asserted that BeiGene “is faking sales in order to persuade investors that it can develop a successful platform in China” and that “management may also be skimming R&D and capital budgets.”

On this news, BeiGene’s American depositary share price fell $19.95 per share, or 14.19%, to close at $120.61 per share on September 6, 2019.

If you purchased or otherwise acquired BeiGene shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at  investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in BeiGene. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: